MRI Scans
7
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy
Bone Conduction Implant and MRI
Registry of Patients for MRI With Non-MRI Conditional Pacemakers and ICD Non-MRI Conditional Pacemakers and ICD
Structural Cartography of the Insula in Temporal Epilepsy Patients
New MRI Methods Applied to Heart Failure With Preserved Ejection Fraction (HFpEF)
Comparison of Quantitative MRI Perfusion Methods With Quantitative PET Perfusion Imaging
TMJ Fibrocartilage Detection Using MRI